Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 80 (RPL7AP80)

Target
RPL7AP80
Molecular classification
Pseudogene
01

Overview

Ribosomal protein L7a pseudogene 80 (RPL7AP80) is a human pseudogene—an inactive, non-protein-coding segment of DNA that shares high sequence similarity with the functional ribosomal protein L7a gene (RPL7A)[2][4]. As a processed pseudogene, RPL7AP80 has lost its protein-coding capability and does not produce a functional ribosomal protein. Pseudogenes like RPL7AP80 may occasionally have regulatory roles, such as acting as competing endogenous RNAs or producing regulatory non-coding RNAs, but there is no specific evidence supporting such a function for this particular pseudogene[6]. RPL7AP80 is not a therapeutic target and does not interact with known drugs. It is not associated with specific diseases, nor used as a biomarker or implicated in therapeutic safety concerns. The functional parent gene, RPL7A, encodes a component of the 60S ribosomal subunit critical for protein synthesis[1][3]. Pseudogenes are generally considered non-functional remnants of genes, although research has shown some may regulate expression of related protein-coding genes in certain contexts[6]. RPL7AP80 is recognized formally by human gene nomenclature authorities as a validated pseudogene[2].

Other names
RPL7AP80
02

Biological functions

No established function (potential non-coding RNA regulation not established for this specific pseudogene)
03

Disease associations

No direct involvement in disease documented

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 80 (RPL7AP80).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 80 (RPL7AP80).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call